The global AI in drug repurposing market was valued at USD 1.01 billion in 2024 and is forecasted to grow at a CAGR of 20.1% through 2034, as artificial intelligence transforms every stage of drug discovery and repositioning. The market’s segmentation structure is multi-dimensional, spanning applications, end-users, and technology types that collectively define its growth trajectory....